Trending Stock News

EPS for Cantel Medical Corp. (CMD) Expected At $0.60

Analysts expect Cantel Medical Corp. (NYSE:CMD) to report $0.60 EPS on December, 6.They anticipate $0.03 EPS change or 5.26 % from last quarter’s $0.57 EPS. CMD’s profit would be $25.03 million giving it 34.70 P/E if the $0.60 EPS is correct. After having $0.62 EPS previously, Cantel Medical Corp.’s analysts see -3.23 % EPS growth. The stock decreased 1.79% or $1.52 during the last trading session, reaching $83.29. About 240,017 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 15.63% since November 9, 2017 and is uptrending. It has outperformed by 0.01% the S&P500.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $3.47 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 38.21 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Another recent and important Cantel Medical Corp. (NYSE:CMD) news was published by which published an article titled: “Cantel Appoints Bill Haydon to Senior Vice President and General Manager of Medical Division” on November 01, 2018.

Cantel Medical Corp. (NYSE:CMD) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *